Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 11:31 p.m.	usa	Rate of adverse events related to the infusion of anti-SARS-CoV-2 immunoglobulin through CTCAE v4.0.;Clearence of viral RNA evaluated by RT-PCR	Rate of adverse events related to the infusion of anti-SARS-CoV-2 immunoglobulin through CTCAE v4.0.;Clearence of viral RNA evaluated by RT-PCR